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Discovery of a family of γ-aminobutyrate ureas via rational 
derepression of a silent bacterial gene cluster
Mining the genomes of Streptomyces bacteria has revealed a vast 
number of gene clusters proposed to direct the biosynthesis of 
novel antibiotic-like natural products. However, many of these 
genes are poorly expressed under laboratory growth conditions. 
In this study, we have addressed this problem via genetic 
inactivation of a pathway-speciﬁ c transcriptional repressor. 
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86 | Chem. Sci., 2014, 5, 86–89Discovery of a family of g-aminobutyrate ureas via
rational derepression of a silent bacterial gene
cluster†
John D. Sidda,ab Lijiang Song,a Vincent Poon,ab Mahmoud Al-Bassam,c Orestis Lazos,a
Mark J. Buttner,c Gregory L. Challisa and Christophe Corre*ab
Gaburedins, a family of g-aminobutyrate (GABA)-derived ureas, have been discovered by deletion of gbnR,
an arpA-like putative transcriptional repressor in Streptomyces venezuelae ATCC 10712. Comparison of
metabolite proﬁles in the wild type and mutant strains revealed six metabolites in the mutant that are
lacking from the wild type. The structure of gaburedin A was established by HRMS combined with 1- and
2-D NMR spectroscopy and was conﬁrmed by total synthesis. The other metabolites were conﬁrmed as
congeners using HRMS, MS/MS and feeding of putative biosynthetic precursors. Two genes, gbnA and
gbnB, are proposed to be involved in gaburedin biosynthesis. Consistent with this hypothesis, deletion of
gbnB in the gbnR mutant abolished gaburedin production. This is the ﬁrst report to disclose the
discovery of novel natural products via rational deletion of a putative pathway-speciﬁc regulatory gene.Streptomyces are soil-dwelling, lamentous bacteria that produce
a remarkably diverse range of bioactive natural products. Such
molecules nd use in the treatment of infectious diseases, cancer
and transplant rejection, as well as in agriculture. Indeed, almost
70% of commercially-available antibiotics originate from the
Streptomyces genus.1 Classical methods for identication of novel
natural products have focused on screening cultures for specic
bioactivities. However, these approaches oen result in the re-
discovery of known compounds. Alternative strategies are there-
fore required for the discovery of novel bioactive natural products
from microbial sources.2
The recent explosion in the availability of bacterial genome
sequences has led to the identication of many cryptic natural
product biosynthetic gene clusters.3 These oﬀer a promising
resource for novel natural product discovery.3 However, many
cryptic biosynthetic gene clusters are expressed poorly or not at
all under laboratory growth conditions.4,5 Rational approaches
are therefore required to induce the expression of such silent
biosynthetic pathways.
In addition to biosynthetic and self-resistance genes, single
or multiple genes encoding transcriptional regulators (activa-
tors or repressors) are typically present in bacterial natural
product biosynthetic gene clusters.5 Recently, it has been
reported that the constitutive expression of a putative pathway-arwick, Coventry, CV4 7AL, UK. E-mail:
24 112; Tel: +44 (0)2476 523 557
ick, Coventry, CV4 7AL, UK
n Innes Centre, Norwich, NR4 7UH, UK
(ESI) available: Strains and plasmids,
See DOI: 10.1039/c3sc52536hspecic transcriptional activator results in the production of a
novel complex of macrolide antibiotics by S. ambofaciens.4 A
similar strategy has been employed in Aspergillus nidulans to
discover the product of a cryptic biosynthetic pathway.6 Dele-
tion of putative bacterial pathway-specic transcriptional
repressors has been investigated as a complementary approach,
but has yet to result in the discovery of novel metabolites.7,8
ArpA-like transcriptional repressors belong to the TetR-family of
DNA-binding proteins and are known to control the production
of a wide variety of antibiotics.9,10 ArpA itself controls the
production of streptomycin in Streptomyces griseus.11 The
biosynthesis of several other natural products is repressed by
ArpA-like proteins and inactivation of arpA-like genes generally
boosts production levels, e.g. deletion of mmyR in Streptomyces
coelicolor has been shown to result in the overproduction of
methylenomycin antibiotics.12
ArpA-like proteins have been shown to sense and respond to
specic ligands such as g-butyrolactones, 2-alkyl-4-hydrox-
ymethylfuran-3-carboxylic acids (AHFCAs) and butenolides.13–17 In
particular, the methylenomycin furans, assembled by the prod-
ucts of the mmfLHP genes, act as methylenomycin production
inducers in S. coelicolor. These signalingmolecules are thought to
interact with the ArpA-like transcriptional repressors MmfR and/
or MmyR.12,14 Even though MmfR and MmyR share 35% identity
and 56% similarity, the phenotypes of mmfR and mmyR mutants
are distinct. The strain lacking mmyR overproduces the methyl-
enomycin antibiotics, whereas the strain lacking mmfR exhibits a
phenotype similar to the wild type strain.12
BLAST searches revealed that several Streptomyces
genomes contain a cassette of ve genes homologous toThis journal is © The Royal Society of Chemistry 2014
Fig. 2 LC-MS analysis of S. venezuelae gbnRmutant (blue trace), wild
type (red trace) and gbnR/gbnB double mutant (green trace) strains.
Extracted ion chromatograms form/z ¼ 246.9 (gaburedin D, 4); 260.9
(gaburedin B/C, 2/3); 279.0 (gaburedin F, 6); 292.9 (gaburedin E, 5); and
294.9 (gaburedin A, 1) are shown, highlighting the metabolites iden-
tiﬁed in the gbnRmutant that are absent from the wild type and double
mutant strains.
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View Article OnlinemmfR–mmfLHP–mmyR. These are proposed to be involved in the
transcriptional regulation of specic natural product biosyn-
thetic pathways.14 Thus, inactivation of the mmyR homologues
in these genomes was predicted to result in induction of the
biosynthetic gene clusters under their control and biosynthesis
of the corresponding metabolic products.
The genome sequence of Streptomyces venezuelae ATCC 10712
became publicly available in 2012, revealing a cluster of genes that
contains the mmyR homologue gbnR (sven_4187), as well as the
mmfR homologue sgnR (sven_4182) and the mmfLHP homologues
sgnLPH (sven_4183, 4185 and 4188; Fig. 1). This putative regulatory
system is located adjacent to gbnABC (sven_4179–4181), which
encode potential natural product biosynthetic and export proteins.
In silico analysis of the gbn gene cluster revealed highly
conserved DNA sequences in the sgnR-sgnL and gbnR-sgnH
intergenic regions as well as in the promoter region of gbnA
(Fig. 1). These conserved DNA sequences are proposed to be
binding sites for GbnR (Fig. 1). As a consequence, GbnR was
predicted to act as a repressor of the gbnABC operon, which
should therefore be constitutively expressed if gbnR is deleted.
Here we report that inactivation of gbnR in S. venezuelae
induces production of the gaburedins, a novel family of g-
aminobutyrate ureas. To the best of our knowledge, this is the
rst example of the discovery of a novel family of bacterial
natural products via rational manipulation of a putative
pathway-specic repressor gene.
The S. venezuelae gbnR::apr mutant was constructed using
PCR-targeting (see ESI†).18 The gbnR::apr and wild type strains
were grown on a supplementedminimal agar medium for 3 days,
aer which the acidied agar medium was extracted with ethyl
acetate. The extracts were dried and re-suspended in water–
methanol (1:1). Metabolites produced by the wild type and
mutant strains were analysed by high resolution LC-MS/MS.
Comparison of the base peak chromatograms revealed six
metabolites (1–6), named gaburedins, which were produced by
the gbnR::apr mutant strain but not the wild type strain (Fig. 2).
The molecular formulae of the metabolites were deduced to
be C14H18N2O5 for 1, C11H20N2O5 for 2 and 3, C10H18N2O5 for 4,Fig. 1 Organisation of the gbn/sgn gene cluster (9.2 kb) that regulates
and directs gaburedin production in S. venezuelae ATCC 10712 and
proposed functions of the encoded proteins.
This journal is © The Royal Society of Chemistry 2014C10H16N2O6S for 5 and C10H18N2O5S for 6. A neutral loss of 129
Da was observed for each parent ion in the MS/MS spectrum,
corresponding to loss of a common C5H7NO3 fragment (Fig. 3).
Interestingly, the molecular formulae of the resulting
daughter ions matched those of the protonated amino acids
phenylalanine, isoleucine/leucine, valine and methionine for
compounds 1, 2/3, 4 (Fig. 5) and 6 respectively. For compound 5,
the molecular formulae for the daughter ion matched that of
acetylcysteine (C5H10NO3S). A further loss of a 42 Da fragment
from this daughter ion was consistent with the presence of an
acetyl group. An analogous fragmentation pattern was observed
for the [M + Na]+ ions of each gaburedin.
Cultures of the gbnR::apr mutant were scaled up to isolate
suﬃcient quantities of 1 for structure elucidation by NMR spec-
troscopy (Fig. 4). COSY and HMBC experiments allowed unam-
biguous elucidation of the planar structure. An authentic
standard of S-1 was synthesised via modication of the route
reported by Tayaka and co-workers for the synthesis of ureido-
containing derivatives of 5-uorouracil (Fig. 4).19 LC-MS/MS and
NMR analyses conrmed that the compound puried from the
gbnR::aprmutant strain was identical to the synthetic standard 1.Fig. 3 High resolution MS data for gaburedin D (4), C (3), B (2) and A (1)
(top panel to bottom panel, respectively), highlighting the neutral loss
of 129 Da observed for all gaburedins.
Chem. Sci., 2014, 5, 86–89 | 87
Fig. 5 Structures of gaburedins A–D (1–4) isolated from the S. ven-
ezuelae gbnR::apr mutant, showing the conserved GABA fragment
(boxed) common to all gaburedins.
Fig. 4 Structure elucidation and total synthesis of gaburedin A 1. Bold
lines represent COSY correlations and arrows represent HMBC
correlations observed for the sample of 1 isolated from S. venezuelae.
Scheme 1 Proposed pathways for gaburedin biosynthesis.
Chemical Science Edge Article
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View Article OnlineSupplementation of the culture medium with specic amino
acids was found to inuence gaburedin production. For
example, growth of the gbnR::apr mutant in a culture medium
enriched in L-phenylalanine (20 mM nal concentration)
resulted in overproduction of gaburedin A 1 relative to the other
gaburedin congeners. Feeding with D-phenylalanine resulted in
the overproduction of a gaburedin with same retention time
and fragmentation pattern as 1. However, chiral HPLC analysis
indicated that this compound was the enantiomer of 1, con-
rming that the absolute conguration of 1 initially isolated
from S. venezuelae is S (ESI†).
The gbnR::apr mutant was grown in culture media supple-
mented with either L-isoleucine or L-leucine (20 mM nal
concentration) to distinguish between gaburedin B 2 and
gaburedin C 3 which have very similar retention times (Fig. 2).
The resulting culture extracts were analysed by LC-MS/MS,
revealing that the quantity of 3 increased dramatically when
L-isoleucine was fed, whereas the quantity of 2 signicantly
increased in the culture extract obtained from the mutant
grown in the presence of L-leucine (see ESI†). Specic incorpo-
ration of d10-leucine into 2 and d10-isoleucine into 3 further
conrmed the structural identity of these metabolites (ESI†).
Similarly the gbnR::aprmutant strain was grown in the presence
of N-acetylcysteine, in which case gaburedin E 5 was over-
produced. Further precursor-directed biosynthesis experiments
were carried out by supplementing the culture medium with
various amino acids and gaburedins containing Val, Met, Tyr,
Trp, Gly, Ala, Pro, Ser, Thr and Glu were identied by LC-MS
analyses (see ESI†). The molecular formulae, fragmentation88 | Chem. Sci., 2014, 5, 86–89patterns and retention times were all consistent with the
proposed structures (see ESI†). Interestingly supplementation
with g-aminobutyrate (GABA) resulted in the production of a
GABA dimer (7), in which the two monomers are linked by a
ureido bridge (molecular formulae C9H16N2O5, Scheme 1).
Amino acid analogues lacking the carboxylic acid group were
also incorporated into gaburedin analogues, e.g. isobutylamine
was found to elicit the production of compound 8 (Scheme 1).
The gbnA gene encodes a putative pyridoxal phosphate (PLP)-
dependent amino acid decarboxylase (Fig. 1), which is proposed
to decarboxylate glutamate to give GABA (Scheme 1). Interest-
ingly, feeding of the S. venezuelae gbnR mutant with glutamate
not only yielded the glutamate-derived gaburedin analogue but
also analogue 7, consistent with the hypothesis that GABA is
derived from decarboxylation of glutamate. The gbnB gene
encodes a putative ATP-dependent enzyme belonging to the
acyl-CoA synthetase superfamily (Fig. 1). GbnB is proposed to
adenylate either the carboxyl or the carbamoyl group of
compound 9, which derives from the spontaneous reaction of
GABA with CO2 (Scheme 1). Carboxyl adenylate 10 would need
to undergo cyclisation to the N-carboxyanhydride 11, which
would then aﬀord the gaburedins via ring opening with amino
acids (note, however, that this would involve nucleophilic attack
at the less electrophilic carbonyl group of 11, which is chemi-
cally unlikely). On the other hand, the carbamoyl adenylate 12
could react with the appropriate amino acids either directly, or
via anhydride 11, to form the gaburedins. Deletion of gbnB in
the gbnR mutant of S. venezuelae abolished gaburedin produc-
tion (Fig. 2), consistent with the key role proposed for GbnB in
gaburedin biosynthesis. GbnA and GbnB appear to be the only
two enzymes required for gaburedin biosynthesis. GbnC is
proposed to export either the gaburedins or intermediate 11/12,
which could react with amino acids in the extracellular milieu to
form the gaburedins.This journal is © The Royal Society of Chemistry 2014
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View Article OnlineA handful of other urea-containing natural products are
known, such as the syringolins and the pacidamycins.20–22
Interestingly, the adenylation domain of SylC, which has been
shown to catalyze urea formation in syringolin biosynthesis,
shares 39% similarity and 22% identity with GbnB.20 The
mechanism for SylC-catalyzed urea formation has been
proposed to involve a ve-membered cyclic N-carboxyanhy-
dride, or a closely related species.20 This anhydride is hypothe-
sized to be formed via an analogous mechanism to that
suggested for the formation of 11 (Scheme 1). Trapping of the
anhydride with an isoleucyl or valinyl acyl carrier protein thio-
ester would lead to formation of the ureido linkage of the
syringolins. As noted above, an analogous mechanism for the
formation of the gaburedins via intermediate 11 seems unlikely.
Thus, further experiments are required to establish whether
similar or distinct mechanisms are utilized for urea formation
in syringolin and gaburedin biosynthesis.
Interestingly, BLAST searches revealed analogous operons to
the gbnABC operon in other bacteria such as Streptococcus
mutans, Salmonella enterica and Vibrio vulnicus (see ESI†).
Surprisingly, most of these are clinical isolates of opportunistic
pathogens. It will be important, therefore, to establish the
nature of the metabolites produced by these strains and to
investigate the role of gaburedins and related molecules in
pathogenicity.Conclusions
In summary, bioinformatics analyses suggested that expres-
sion of the gbnABC gene is controlled by the putative pathway-
specic transcriptional repressor GbnR in S. venezuelae.
Inactivation of gbnR resulted in derepression of the gbn gene
cluster, resulting in the discovery of the gaburedins, a novel
class of urea natural products. To the best of our knowledge,
this is the rst report of novel natural product discovery via
rational manipulation of a pathway specic transcriptional
repressor gene, an approach that oﬀers considerable potential
for activation of silent biosynthetic pathways in Streptomyces
species, which could lead to the discovery of a wide variety of
new metabolites.Acknowledgements
This work was mainly supported by a University Research
Fellowship (UF090255) from The Royal Society and by an EPSRC
DTA studentship to J. D. Sidda. The Bruker MaXis mass spec-
trometer used in this research was obtained with support from
AWM and the ERDF. The authors would also like to thank Dr
David J. Fox for helpful discussions.This journal is © The Royal Society of Chemistry 2014Notes and references
1 D. A. Hopwood, Streptomyces in Nature and Medicine: The
Antibiotic Makers, Oxford University Press, New York, 2007.
2 F. E. Koehn and G. T. Carter, Nat. Rev. Drug Discovery, 2005,
4, 206–220.
3 M. Zerikly and G. L. Challis, ChemBioChem, 2009, 10, 625–633.
4 L. Laureti, L. Song, S. Huang, C. Corre, P. Leblond,
G. L. Challis and B. Aigle, Proc. Natl. Acad. Sci. U. S. A.,
2011, 108, 6258–6263.
5 G. Liu, K. F. Chater, G. Chandra, G. Niu and H. Tan,
Microbiol. Mol. Biol. Rev., 2013, 77, 112–143.
6 S. Bergmann, J. Schu¨mann, K. Scherlach, C. Lange,
A. A. Brakhage and C. Hertweck, Nat. Chem. Biol., 2007, 3,
213–217.
7 M. Gottelt, S. Kol, J. P. Gomez-Escribano, M. J. Bibb and
E. Takano, Microbiology, 2010, 156, 2243–2253.
8 R. Bunet, L. Song, M. V. Mendes, C. Corre, L. Hotel,
N. Rouhier, X. Framboisier, P. Leblond, G. L. Challis and
B. Aigle, J. Bacteriol., 2011, 193, 1142–1153.
9 J. L. Ramos, M. Mart´ınez-Bueno, A. J. Molina-Henares,
W. Tera´n, K. Watanabe, X. Zhang, M. T. Gallegos,
R. Brennan and R. Tobes, Microbiol. Mol. Biol. Rev., 2005,
69, 326–356.
10 L. Cuthbertson and J. R. Nodwell, Microbiol. Mol. Biol. Rev.,
2013, 77, 440–475.
11 Y. Ohnishi, S. Kameyama, H. Onaka and S. Horinouchi,Mol.
Microbiol., 1999, 34, 102–111.
12 S. O’Rourke, A. Wietzorrek, K. Fowler, C. Corre, G. L. Challis
and K. F. Chater, Mol. Microbiol., 2009, 71, 763–778.
13 H. Nishida, Y. Ohnishi, S. Horinouchi and T. Beppu, Environ.
Microbiol., 2007, 9, 1986–1994.
14 C. Corre, L. Song, S. O’Rourke, K. F. Chater and G. L. Challis,
Proc. Natl. Acad. Sci. U. S. A., 2008, 105, 17510–17515.
15 S. Kitani, K. T. Miyamoto, S. Takamatsu, E. Herawati,
H. Iguchi, K. Nishitomi, M. Uchida, T. Nagamitsu,
S. Omura, H. Ikeda and T. Nihira, Proc. Natl. Acad. Sci. U.
S. A., 2011, 108, 16410–16415.
16 J. M. Willey and A. A. Gaskell, Chem. Rev., 2011, 111, 174–187.
17 K. Arakawa, N. Tsuda, A. Taniguchi and H. Kinashi,
ChemBioChem, 2012, 13, 1447–1457.
18 B. Gust, G. L. Challis, K. Fowler, T. Kieser and K. F. Chater,
Proc. Natl. Acad. Sci. U. S. A., 2003, 100, 1541–1546.
19 T. Tayaka and Z. Tozuka,US Pat., 4,349,552, 14 September 1982.
20 H. J. Imker, C. T. Walsh and W. M. Wuest, J. Am. Chem. Soc.,
2009, 131, 18263–18265.
21 E. J. Rackham, S. Gru¨schow, A. E. Ragab, S. Dickens and
R. J. M. Goss, ChemBioChem, 2010, 11, 1700–1709.
22 W. Zhang, I. Ntai, M. L. Bolla, S. J. Malcolmson, D. Kahne,
N. L. Kelleher and C. T. Walsh, J. Am. Chem. Soc., 2011,
133, 5240–5243.Chem. Sci., 2014, 5, 86–89 | 89
